Triglyceride-glucose related indices as predictors for major adverse cardiovascular events and overall mortality in type-2 diabetes mellitus patients

被引:0
|
作者
Liu, Mao-Jun [1 ]
Pei, Jun-Yu [1 ]
Zeng, Cheng [1 ]
Xing, Ying [1 ]
Zhang, Yi-Feng [1 ]
Tang, Pei-Qi [1 ]
Deng, Si-Min [1 ]
Hu, Xin-Qun [1 ]
机构
[1] Cent South Univ, Xiangya Hosp 2, Dept Cardiovasc Med, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China
关键词
Triglyceride-glucose related indices; Major adverse cardiovascular events; Overall mortality; Type 2 diabetes mellitus; Action to control cardiovascular risk in diabetes; INSULIN-RESISTANCE; OBESITY PARADOX; RISK; ASSOCIATION; ADIPOSITY;
D O I
10.4239/wjd.v16.i3.101488
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Recent studies have indicated that triglyceride glucose (TyG)-waist height ratio (WHtR) and TyG-waist circumference (TyG-WC) are effective indicators for evaluating insulin resistance. However, research on the association in TyG-WHtR, TyG-WC, and the risk and prognosis of major adverse cardiovascular events (MACEs) in type 2 diabetes mellitus (T2DM) cases are limited. AIM To clarify the relation in TyG-WHtR, TyG-WC, and the risk of MACEs and overall mortality in T2DM patients. METHODS Information for this investigation was obtained from Action to Control Cardiovascular Risk in Diabetes (ACCORD)/ACCORD Follow-On (ACCORDION) study database. The Cox regression model was applied to assess the relation among TyG-WHtR, TyG-WC and future MACEs risk and overall mortality in T2DM cases. The RCS analysis was utilized to explore the nonlinear correlation. Subgroup and interaction analyses were conducted to prove the robustness. The receiver operating characteristic curves were applied to analysis the additional predicting value of TyG-WHtR and TyG-WC. RESULTS After full adjustment for confounding variables, the highest baseline TyG-WHtR cohort respectively exhibited a 1.353-fold and 1.420-fold higher risk for MACEs and overall mortality, than the lowest quartile group. Similarly, the highest baseline TyG-WC cohort showed a 1.314-fold and 1.480-fold higher risk for MACEs and overall mortality, respectively. Each 1 SD increase in TyG-WHtR was significantly related to an 11.7% increase in MACEs and a 14.9% enhance in overall mortality. Each 1 SD increase in TyG-WC corresponded to an 11.5% in MACEs and a 16.6% increase in overall mortality. Including these two indexes in conventional models significantly improved the predictive power for MACEs and overall mortality. CONCLUSION TyG-WHtR and TyG-WC were promising predictors of MACEs and overall mortality risk in T2DM cases.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] Association between the triglyceride-glucose index and 1-year major adverse cardiovascular events in patients with coronary heart disease and hypertension
    Tao, Shiyi
    Yu, Lintong
    Li, Jun
    Huang, Li
    Huang, Xuanchun
    Zhang, Wenjie
    Xie, Zicong
    Tan, Yuqing
    Yang, Deshuang
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [22] Predictive value of triglyceride-glucose index for the evaluation of coronary artery disease severity and occurrence of major adverse cardiovascular events
    Siverio-Morales, Orlando
    Mora-Fernandez, Carmen
    Hernandez-Carballo, Carolina
    Martin-Nunez, Ernesto
    Gonzalez-Luis, Ainhoa
    Martin-Olivera, Alberto
    Navarro-Gonzalez, Juan F.
    Donate-Correa, Javier
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2025, 328 (01): : H14 - H20
  • [23] Role of Triglyceride-Glucose Index in Type 2 Diabetes Mellitus and Its Complications
    Pan, Ying
    Zhao, Mengjie
    Song, Tiantian
    Tang, Jia
    Kuang, Ming
    Liu, Hongying
    Zhong, Shao
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 3325 - 3333
  • [24] Predictive Value of Triglyceride-Glucose Index for All-Cause and Cardiovascular Mortality in Patients With Diabetes Mellitus: A Retrospective Study
    Feng, Xiaoxuan
    Deng, Yishou
    Chen, Chaolei
    Liu, Xiaocong
    Huang, Yuqing
    Feng, Yingqing
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2024, 2024
  • [25] Triglyceride-glucose index as a potential predictor of major adverse cardiovascular and cerebrovascular events in patients with coronary heart disease complicated with depression
    Zhao, Weizhe
    Wang, Junqing
    Chen, Dong
    Ding, Wanli
    Hou, Jiqiu
    Gui, YiWei
    Liu, Yunlin
    Li, Ruiyi
    Liu, Xiang
    Sun, Zhiqi
    Zhao, Haibin
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [26] The predictive significance of the triglyceride-glucose index in forecasting adverse cardiovascular events among type 2 diabetes mellitus patients with co-existing hyperuricemia: a retrospective cohort study
    Jianyong Zhao
    Na Li
    Shiqi Li
    Jiaqing Dou
    Cardiovascular Diabetology, 24 (1)
  • [27] Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients without diabetes mellitus after coronary artery bypass grafting: a multicenter retrospective cohort study
    Wu, Zhenguo
    Xie, Lin
    Guo, Dachuan
    Chen, Sha
    Liu, Xiaoyu
    Sun, Xiangfei
    Wang, Juan
    Zhang, Yerui
    Liu, Li
    Cui, Huiliang
    Zang, Dejin
    Yang, Jianmin
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [28] N-acetylcysteine therapy reduces major adverse cardiovascular events in patients with type 2 diabetes mellitus
    Sun, Mingyang
    Lu, Zhongyuan
    Chen, Wan-Ming
    Lv, Shuang
    Fu, Ningning
    Yang, Yitian
    Wang, Yangyang
    Miao, Mengrong
    Wu, Szu-Yuan
    Zhang, Jiaqiang
    ATHEROSCLEROSIS, 2025, 402
  • [29] Influence of the Triglyceride-Glucose Index on Adverse Cardiovascular and Cerebrovascular Events in Prediabetic Patients With Acute Coronary Syndrome
    Guo, Qianyun
    Feng, Xunxun
    Zhang, Bin
    Zhai, Guangyao
    Yang, Jiaqi
    Liu, Yang
    Liu, Yuyang
    Shi, Dongmei
    Zhou, Yujie
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [30] Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study
    Wu, Zhenguo
    Liu, Li
    Wang, Weiwei
    Cui, Huiliang
    Zhang, Yerui
    Xu, Jiechang
    Zhang, Wencheng
    Zheng, Tengfei
    Yang, Jianmin
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)